IFNG and neoplasm: Effector tumor-specific T cells amplify and move through blood flow into the tumor microenvironment (TME) to induce tumor destruction through cytotoxicity and the production of certain cytokines [e.g., interferon (IFN)-γ and tumor necrosis factor (TNF)-α].